| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.28 | 0.3 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.3 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.068 | 0.3 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |